Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Cerba buys Novescia

PAI-backed Franco-Belgian lab group Cerba is to buy Novescia, the national French lab chain for €275m. We reflect on the deal and the state of the lab market.

Euromedic to rebrand – interview to follow

Euromedic, the largest European imaging service provider and which is also active in labs and radiotherapy, is to rebrand as Affidea. We will carry an interview on the move with CEO Dimitris Moulavasilis tomorrow.

IDH announces London IPO in February

Egyptian lab group IDH (Integrated Diagnostics Holdings) is using Egypt’s more settled political situation to cash in on mega-profits. The group expects a market capitalisation of $600m at IPO and could float up to 45% of the share capital. Before tax profits came to $21m, a margin of 25%, in the financial year ending 30 Sep 2014, on sales of $87m, up 27.5%. EBITDA margin stands at 42%.

Interview: Franceso Longo, director, CERGAS

Professor Longo is a long-term analyst of the Italian NHS and the private sector. Here he predicts a boom for the private sector in all forms of post-acute care, explains why he expects private medical insurance to grow steeply and looks at how the private sector is acquiring not-for-profit operators.

Interview: Ameera Shah, Owner & Managing Director, Metropolis Healthcare

Interview: Ameera Shah, Owner & Managing Director, Metropolis Healthcare. Ameera set up Metropolis when she was just 20. Fourteen years on, the business is one of the big three labs in India. It is the only one of the big three to expand abroad with lab operations in seven countries across Africa, the Middle East and Sri Lanka. It carries out 15 million tests a year through 125 labs and 800 phlebotomy centres. Ameera is also speaking at our annual conference in London on April 28, 2015.

French tribunal ruling gets ONP monkey off Labco’s back

The General Court of the European Union confirms a prior ruling that the ONP (The French National Order of Pharmacists), a professional body, restricted competition in the biomedical testing market. Labco is now free to pursue consolidation in France and will foster more competition in the labs and diagnostics market.

Three French lab operators for sale

Three leading French national lab operators are up for sale. This comes as French laboratories are facing increased pressure to adapt to new regulations on capital shares and voting rights.

Find Us